Sophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rollout
Under the collaboration, AstraZeneca will support the rollout of MSK-ACCESS to 20 global locations over the next 12 months.
Under the collaboration, AstraZeneca will support the rollout of MSK-ACCESS to 20 global locations over the next 12 months.
Results from AstraZeneca’s completed clinical studies will be shared with regulatory authorities by the end of this year.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Exer AI and Mayo Clinic unite to treat hand and wrist disorders using AI
As mpox spreads, ‘national governments have a moral responsibility to help’
Ultromics’s EchoGo misses primary endpoint in heart disease trial
Ketryx tackles software safety in medical devices amid growing recalls